Overview of Dr. Schneider
Dr. Julie Schneider is a neurologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Loyola University Medical Center. She received her medical degree from University of Illinois College of Medicine at Chicago and has been in practice 30 years. She is one of 218 doctors at Rush University Medical Center and one of 345 doctors at Loyola University Medical Center who specialize in Neurology. She has more than 100 publications and over 500 citings.
Office
1750 W. Harrison St
Suite 1000
Chicago, IL 60612
Education & Training
- Emory University School of MedicineFellowship, Neuropathology, 1993 - 1994
- University of ChicagoResidency, Neurology, 1988 - 1993
- Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1987 - 1988
- University of Illinois College of MedicineClass of 1987
Certifications & Licensure
- IL State Medical License 1988 - 2026
- GA State Medical License 1993 - 1997
- American Board of Pathology Neuropathology
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Vascular endothelial growth factor receptor-1 (FLT1) interactions with amyloid-beta in Alzheimer's disease: A putative biomarker of amyloid-induced vascular damage.Rebecca L Winfree, Emma Nolan, Kaj Blennow, Henrik Zetterberg, Katherine A Gifford
Neurobiology of Aging. 2025-03-01 - Evaluating the association ofgenotype and cognitive resilience in SuperAgers.Alaina Durant, Shubhabrata Mukherjee, Michael L Lee, Seo-Eun Choi, Phoebe Scollard
Medrxiv. 2025-01-07 - Sex-specific Associations of Gene Expression with Alzheimer's Disease Neuropathology and Ante-mortem Cognitive Performance.Mabel Seto, Michelle Clifton, Melisa Lara Gomez, Gillian Coughlan, Katherine A Gifford
Biorxiv. 2025-01-02
Journal Articles
- Sex Differences in Alzheimer’s Disease and Common Neuropathologies of AgingZoe Arvanitakis, Julie A Schneider, Lei Yu, David A Bennett, Acta Neuropathologica
- The Human Brainome: Network Analysis Identifies HSPA2 as a Novel Alzheimer’s Disease TargetChristine M Hulette, David A Bennett, Roger L Albin, Thomas G Beach, Randall L Woltjer, Andrew P Lieberman, John F Ervin, Anzhelika Engel, Julie A Schneider, Rui Chang, Brain
Press Mentions
- Strawberries May Help Fend off Alzheimer'sJuly 20th, 2022
- Newly Recognized Dementia Called LATE May Hit 40 Percent of Older PeopleJuly 13th, 2022
- Newly Recognized Dementia Called Late May Affects 40 Percent of Older PeopleJuly 13th, 2022
- Join now to see all
Grant Support
- Core--NeuropathologyNational Institute On Aging2006–2010
- Epidemiology, Pathology, And Parkinsonism In AgingNational Institute On Aging2000–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: